Inder S Anand
Inder S Anand
Professor of Medicine, University of Minnesota, Minneapolis and Director, Hear Failure Program, VA
Verifierad e-postadress på
Citeras av
Citeras av
Spironolactone for heart failure with preserved ejection fraction
B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ...
N Engl J Med 370, 1383-1392, 2014
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
IS Anand, LD Fisher, YT Chiang, R Latini, S Masson, AP Maggioni, ...
Circulation 107 (9), 1278-1283, 2003
R Latini, S Masson, IS Anand, E Missov, M Carlson, T Vago, L Angelici, ...
Circulation 116 (11), 1242-1249, 2007
Clinical perspective
MR Zile, TD Bennett, M St. John Sutton, YK Cho, PB Adamson, MF Aaron, ...
Circulation 118 (14), 1433-1441, 2008
Consensus recommendations for the management of chronic heart failure: Introduction
M Packer, JN Cohn, WT Abraham, WS Colucci, MB Fowler, BH Greenberg, ...
American Journal of Cardiology 83 (2 A), 1A-38A, 1999
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial
MA Pfeffer, B Claggett, SF Assmann, R Boineau, IS Anand, N Clausell, ...
Circulation 131 (1), 34-42, 2015
C-reactive protein in heart failure: prognostic value and the effect of valsartan
IS Anand, R Latini, VG Florea, MA Kuskowski, T Rector, S Masson, ...
Circulation 112 (10), 1428-1434, 2005
Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan …
S Masson, R Latini, IS Anand, T Vago, L Angelici, S Barlera, ED Missov, ...
Clinical chemistry 52 (8), 1528-1538, 2006
Treatment of anemia with darbepoetin alfa in systolic heart failure
K Swedberg, JB Young, IS Anand, S Cheng, AS Desai, R Diaz, ...
New England Journal of Medicine 368 (13), 1210-1219, 2013
Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure.
IS Anand, R Ferrari, GS Kalra, PL Wahi, PA Poole-Wilson, PC Harris
Circulation 80 (2), 299-305, 1989
Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT
IS Anand, MA Kuskowski, TS Rector, VG Florea, RD Glazer, A Hester, ...
Circulation 112 (8), 1121-1127, 2005
Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones.
IS Anand, Y Chandrashekhar, R Ferrari, PA Poole-Wilson, PC Harris
Heart 70 (4), 357-362, 1993
Anemia and chronic heart failure: implications and treatment options
IS Anand
Journal of the American College of Cardiology 52 (7), 501-511, 2008
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)
S Masson, R Latini, IS Anand, S Barlera, L Angelici, T Vago, G Tognoni, ...
Journal of the American College of Cardiology 52 (12), 997-1003, 2008
JK Ghali, IS Anand, WT Abraham, GC Fonarow, B Greenberg, H Krum, ...
Circulation 117 (4), 526-535, 2008
Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial
IS Anand, T Kempf, TS Rector, H Tapken, T Allhoff, F Jantzen, ...
Circulation 122 (14), 1387-1395, 2010
Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone
AM Shah, B Claggett, NK Sweitzer, SJ Shah, IS Anand, L Liu, B Pitt, ...
Circulation 132 (5), 402-414, 2015
Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial
RK Premchand, K Sharma, S Mittal, R Monteiro, S Dixit, I Libbus, ...
Journal of cardiac failure 20 (11), 808-816, 2014
Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and …
IS Anand, TS Rector, JG Cleland, M Kuskowski, RS McKelvie, H Persson, ...
Circulation: Heart Failure 4 (5), 569-577, 2011
Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: rationale and design of the PARAGON-HF trial
SD Solomon, AR Rizkala, J Gong, W Wang, IS Anand, J Ge, CSP Lam, ...
JACC: Heart Failure 5 (7), 471-482, 2017
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20